Source article originally published on
Article Summary and/or Excerpt:
A new artificial intelligence (AI) program developed by researchers at the University of Cambridge could help to speed up the development of gene therapies. The program, called “GeneMapper,” uses AI to analyze large amounts of data on genetic mutations, helping researchers to identify which mutations are most likely to cause a particular disease. This information can then be used to develop gene therapies that target the specific mutations that are responsible for the disease. The researchers say that the program could help to speed up the development of gene therapies for a wide range of diseases, including cancer, heart disease, and genetic disorders.
The researchers tested GeneMapper on data from a large genetic study of heart disease, and found that it was able to identify several previously unknown genetic mutations that are associated with the disease. They say that this information could be used to develop new gene therapies for heart disease. The program is also being tested on data from other diseases, such as cancer, and the researchers say that it could be used to develop gene therapies for a wide range of conditions. They believe that the program could be used to analyze data from other genetic studies, which could lead to new discoveries and potential therapies for a wide range of diseases.